Investigation of MDCT Plaque Assessment in patients receiving Cholesterol lowering with Pitavastatin (IMPACT)
Phase of Trial: Phase III
Latest Information Update: 02 Jun 2017
At a glance
- Drugs Pitavastatin (Primary)
- Indications Atherosclerosis; Hypercholesterolaemia
- Focus Therapeutic Use
- Acronyms IMPACT
- 31 May 2017 Status changed from not yet recruiting to completed.
- 19 Nov 2008 New trial record.